THE MEDICINAL USES OF CANNABIS AND ITS CONSTITUENTS

被引：26

作者：

FORMUKONG, EA ^{[1
]}

EVANS, AT ^{[1
]}

EVANS, FJ ^{[1
]}

机构：

[1] UNIV LONDON, SCH PHARM, DEPT PHARMACOGNOSY, 29-39 BRUNSWICK SQ, LONDON WC1N 1AX, ENGLAND

来源：

PHYTOTHERAPY RESEARCH | 1989年 / 3卷 / 06期

关键词：

D O I：

10.1002/ptr.2650030602

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：219 / 231

页数：13

共 178 条

[1]

ABDOUD RT, 1976, CHEST, V70, P480

[2] CANNABINOID WITH CARDIOVASCULAR ACTIVITY BUT NO OVERT BEHAVIORAL-EFFECTS [J].

ADAMS, MD ;

EARNHARDT, JT ;

MARTIN, BR ;

HARRIS, LS ;

DEWEY, WL ;

RAZDAN, RK .

EXPERIENTIA, 1977, 33 (09) :1204-1205

[3]

ADAMS MD, 1976, J PHARMACOL EXP THER, V196, P649

[4] EFFECT OF PROCARBAZINE ON BENZODIAZEPINE RECEPTOR IN MOUSE-BRAIN [J].

AGRAWAL, A ;

ANSARI, AA ;

SETH, PK .

TOXICOLOGY LETTERS, 1981, 9 (02) :171-175

[5] A CLINICAL AND METABOLIC STUDY OF ACUTE INTOXICATION WITH CANNABIS-SATIVA AND ITS ROLE IN THE MODEL PSYCHOSES [J].

AMES, F .

JOURNAL OF MENTAL SCIENCE, 1958, 104 (437) :972-999

[6]

BANERJEE SP, 1975, J PHARMACOL EXP THER, V194, P74

[7] ISOLATION FROM CANNABIS-SATIVA L OF CANNFLAVIN - A NOVEL INHIBITOR OF PROSTAGLANDIN PRODUCTION [J].

BARRETT, ML ;

GORDON, D ;

EVANS, FJ .

BIOCHEMICAL PHARMACOLOGY, 1985, 34 (11) :2019-2024

[8]

BEACONSFIELD P, 1972, NEW ENGL J MED, V287, P20921

[9]

BENMOUYAL E, 1971, Clinical Research, V19, P758

[10]

BENOWITZ NL, 1979, CLIN PHARMACOL THER, V25, P440

← 1 2 3 4 5 6 7 8 9 10 →